BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 475555)

  • 1. Cytotoxic action of diethanolamine oleate on Ehrlich exudative carcinoma in mice, compared with the action of polyoxyethylene sorbitan mono-oleate (Tween 80).
    Witek R; Krupa S; Kubis A
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):321-4. PubMed ID: 475555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxic effect of Tween 80 on Ehrlich ascites cancer cells in mice.
    Kubis A; Witek R; Olszewski Z; Krupa S
    Pharmazie; 1979 Nov; 34(11):745-6. PubMed ID: 545345
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-promoting effects in mouse skin; comparison between oleic acid, sorbitan mono-oleate (span 80), and polyoxyethylene sorbitan mono-oleate (tween 80).
    HOLSTI P
    Ann Med Exp Biol Fenn; 1959; 37():212-5. PubMed ID: 14402841
    [No Abstract]   [Full Text] [Related]  

  • 4. [Potentiation of the antitumoral activity of Daunomycin by Tween 80. In vivo and in vitro study on the ascitic Ehrlich tumor].
    Bossa R; Galatulas I; Piccinini F; Villani F
    G Ital Chemioter; 1973; 20(1-4):55-7. PubMed ID: 4806391
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antispasmodic activity of tween 80 (polyoxyethylene derivative of a sorbitan mono-oleate)].
    COGNI G; MORVILLO V
    Boll Soc Ital Biol Sper; 1952; 28(3):395-8. PubMed ID: 12978122
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxic effect of fatty acids in vitro on Ehrlich exudative carcinoma cells and normal exudative cells (leukocytes).
    Witek R; Kubis A; Masiak M; Krupa S; Skowron S
    Arch Immunol Ther Exp (Warsz); 1977; 25(6):765-71. PubMed ID: 580556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Polysorbate 80 (CAS No. 9005-65-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1992 Jan; 415():1-225. PubMed ID: 12616296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Migration of tween 80-treated tumor cells].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Vopr Onkol; 1977; 23(10):103-4. PubMed ID: 595524
    [No Abstract]   [Full Text] [Related]  

  • 9. NTP Toxicology and Carcinogenesis Studies of Oleic Acid Diethanolamine Condensate (CAS No. 93-83-4) in F344/N Rats and B6C3F1 Mice (Dermal Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Jul; 481():1-198. PubMed ID: 12571682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytotoxic action in vitro of catalytically sulphurated unsaturated fatty acids on Ehrlich's ascites cancer and normal peritoneal exudate (leucocytes).
    Witek R; Kubis A; Krupa S
    Pharmazie; 1984 Jul; 39(7):482-3. PubMed ID: 6387722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans fatty acids in tumor development and the host survival.
    Awad AB
    J Natl Cancer Inst; 1981 Jul; 67(1):189-92. PubMed ID: 6942190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hot tar burns.
    Demling RH; Buerstatte WR; Perea A
    J Trauma; 1980 Mar; 20(3):242. PubMed ID: 7359599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
    Frankfurt OS
    Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and oxidation of elaidic acid by Ehrlich ascites tumor cells.
    Awad AB
    Cancer Biochem Biophys; 1981; 5(2):111-7. PubMed ID: 7248917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of palmitoleic acid on Ehrlich ascites tumor.
    Ito H; Kasama K; Naruse S; Shimura K
    Cancer Lett; 1982; 17(2):197-203. PubMed ID: 7165872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of mouse Ehrlich carcinoma growth inhibition by thiacarpine, an analogue of cytotoxic marine alkaloid polycarpine.
    Agafonova IG; Radchenko OS; Novikov VL; Aminin DL; Stonik VA
    Magn Reson Imaging; 2008 Jul; 26(6):763-9. PubMed ID: 18467060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibiting effect of phenformin (phenethyl biguanide) on the growth of Ehrlich carcinoma].
    Shikhman AR; Lebedev KA; Dil'man VM
    Vopr Onkol; 1981; 27(2):67-9. PubMed ID: 7210598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and properties of monomethoxy poly(ethylene glycol) doxorubicin conjugates linked by an amino acid or a peptide as spacer.
    Caliceti P; Monfardini C; Sartore L; Schiavon O; Baccichetti F; Carlassare F; Veronese FM
    Farmaco; 1993 Jul; 48(7):919-32. PubMed ID: 8397676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of anti-tumor efficacy of injectable Centchroman in mice bearing Ehrlich ascites carcinoma.
    Shenoy BD; Udupa N; Kamath R; Devi PU
    Indian J Physiol Pharmacol; 1999 Apr; 43(2):259-62. PubMed ID: 10365323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vivo action of valinomycin on Ehrlich ascites tumor cells. Inhibition of the proliferative activity of the tumor cells under the action of valinomycin].
    Sorokina IB; Mingareeva LA; Manteĭfel' VM
    Antibiotiki; 1975 Aug; 20(8):701-5. PubMed ID: 1229994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.